The Republican Party's strategy to attack the Affordable Care Act's employer mandate by redefining a full-time employee as someone who works 40 hours a week instead of 30 hours could increase dependence on government-provided health insurance.
In looking to chip away at President Obama's healthcare program, the Republican Party's strategy to redefine a full-time employee as someone who works 40 hours a week instead of 30 hours could increase dependence on government-provided health insurance.
The move to change the defined work week for full-time employees is aimed at the Affordable Care Act's employer mandate, which requires companies with at least 50 full-time employees—defined as people working at least 30 hours or more a week in the law—provide comprehensive and affordable health insurance to 95% of full-time workers or face penalties.
The Congressional Budget Office found that changing the mandate to define full-time employees as people at least 40 hours a week would mean 1 million people get dropped from their employer-sponsored insurance. As a result, between 500,000 and 1 million people would turn to options such as Medicaid, the Children's Health Insurance Program, and the ACA insurance exchanges. The move would increase the national deficit by $45.7 billion over a decade.
Read more at The Washington Post's Wonkblog: http://wapo.st/1zTKKDu
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More